国际生物安全战略探析及对我国生物安全治理的启示

doi:10.20047/j.issn1673-7210.2023.18.43

Abstract
Figure/Table
References (28)
Related Citation (0)

Download: PDF (581 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract In recent years, biosafety has become a common risk and challenge facing the world. European and American countries have introduced biosafety strategies to incorporate biosafety into the national governance system. China has also attached great importance to biosafety, and with the implementation of the biosafety law, China has entered a new stage of governance by the rule of law. Based on the analysis of the key points of the development of biosafety strategies in the United States, Britain, Japan, and Russia, and in combination with the construction of China’s biosafety governance system, China should further strengthen the overall national biosafety strategy, increase the investment in biosafety science and technology, pay attention to the improvement of people’s biosafety basic literacy, form a comprehensive and multi-level support of strategy-technology, state-people, and further establish and improve the national biosafety risk prevention and control and governance system.

Key words： Biosafety Biodefense Biothreat Risk control and management system

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CUI Yanmei LIU Haitao

Cite this article:

CUI Yanmei LIU Haitao. Analysis of global biosafety strategy and enlightenment for the biosafety governance of China[J]. 中国医药导报, 2023, 20(18): 192-196.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.18.43 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I18/192

[1] 中华人民共和国生物安全法[Z].北京：人民出版社，2020.
[2] Dawood FS，Luliano AD，Reed C，et al. Estimated global mor- tality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation：a modelling study [J]. Lancet Infect Dis，2012，12（9）：687-695.
[3] Tracht SM，Valle SYD，Edwards BK. Economic analysis of the use of facemasks during pandemic （H1N1） 2009 [J]. J Theor Biol，2012，300：161-172.
[4] Martin B，Coutard B，Guez T，et al. The methyltransferase do- main of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates，in addition to the cap structure [J]. Nucleic Acids Res，2018，46（15）：7902-7912.
[5] 陈方，张志强，丁陈君，等.国际生物安全战略态势分析及对我国的建议[J].中国科学院院刊，2020，35（2）：204-211.
[6] Antimicrobial Resistance Collaborators. Global burden of bac- terial antimicrobial resistance in 2019：a systematic analysis [J]. Lancet，2022，399（10325）：629-655.
[7] 丁声俊.外来物种侵入对粮食安全的影响及其防控防治措施[J].粮食问题研究，2022（6）：4-8.
[8] Zhou DS，Song HB，Wang JW，et al. Biosafety and biosecurity [J]. J Biosaf Biosecur，2019，1（1）：15-18.
[9] 刘长敏，宋明晶.美国生物防御政策与国家安全[J].国际安全研究，2020，38（3）：96-126，159-160.
[10] 刘术，舒东，刘胡波.美国《生物监测国家战略》简述及分析[J].人民军医，2013，56（5）：525-526.
[11] 宋明晶.美国生物安全智库：两党生物防御委员会分析[J].情报杂志，2021，40（2）：14-20，37.
[12] 高德胜，周笑宇.美国《国家生物安全防御战略》文本解读及其对我国生物安全建设的启示[J].求是学刊，2020， 47（2）：14-22.
[13] 金美玲，马琴怡，郭金鹏，等.美国《阿波罗生物防御计划》介绍[J].公共卫生论坛，2021，37（12）：1853-1856.
[14] Fact sheet：DHS efforts to enhance biodefense in support of the biden administration’s new national biodefense strategy[EB/OL].[2022-10-18]. https：//www.dhs.gov/news/2022/10/ 18/fact-sheet-dhs-efforts-enhance-biodefense-support- biden- administrations-new.
[15] 尹志欣，朱姝.英国生物安全立法与管理对我国的启示[J].科技中国，2021（3）：40-42.
[16] Global Health Security 2014-2019 [EB/OL].[2021-10-14].https：//www.cdc.gov/globalhealth/security/ghsa5year/pdf/ GHSA_PalmCard_Facing.pdf.
[17] Public Health England. PHE Strategy 2020 to 2025：executive summary [EB/OL].[2019-09-10]. https：//www.gov.uk/gov- ernment/publications/phe-strategy-2020-to-2025.
[18] UK Biological Security Strategy [EB/OL].[2018-07-30]. https： //www.gov.uk/government/publications/biological-security- strategy.
[19] New inquiry：government’s approach to infectious diseases and bioweapons examined[EB/OL].[2019-07-18]. https：//com- mittees.parliament.uk/committee/111/national-secu- rity-strategy-joint-committee/news/91638/new-inquiry- governments-approach-to-infectious-diseases-and-bio- we- apons-examined.
[20] 尹晓燕，鞠永涛，贾颖杰.日本生物安全法律法规及管理现状简析[J].口岸卫生控制，2020，26（1），54-57.
[21] 陈方，张志强.日本生物安全战略规划与法律法规体系简析[J].世界科技研究与发展，2020，42（3）：276-287.
[22] Integrated Innovation Strategy 2022/2021/2020 [EB/OL].[2022-06-03]. https：//www8.cao.go.jp/cstp/english/index.html.
[23] 宋琪，丁陈君，陈方.俄罗斯生物安全法律法规体系建设简析[J].世界科技研究与发展，2020，42（3）：288-297.
[24] 李睿思.《俄罗斯生物安全法》分析及启示[J].西伯利亚研究，2020，47（5）：45-55，118.
[25] 于淑杰.俄罗斯新版国家安全战略评析[J].俄罗斯东欧中亚研究，2022（1）：32-47，155.
[26] 司林波，裴索亚.国家生物安全风险防控和治理的影响因素与政策启示——基于扎根理论的政策文本研究[J].中共天津市委党校学报，2021，23（3）：61-71.
[27] 苍岚，谢雨奇，张淑翠.“十四五”时期全球科技发展战略焦点及政策建议[J].机器人产业，2021（3）：12-15.
[28] 王萍.筑牢生物安全法治“防火墙”[J].中国人大，2021（8）：13-14.